A new tool co-developed by investigators from Cedars-Sinai Health Sciences University can predict which of two available chemotherapy options for pancreatic cancer would be more effective for an ...
A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. The test combines four protein biomarkers to better distinguish cancer from noncancerous ...
Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more ...
Scientists at Duke-NUS Medical School have identified a molecular "switch" that determines whether pancreatic cancer cells resist chemotherapy or respond to it—a finding that could help convert some ...
Researchers in Spain have developed a new therapy protocol that could revolutionize the treatment of pancreatic cancer. Notoriously aggressive and difficult to treat, pancreatic cancer is rarely ...
Scientists from Oregon Health & Science University have developed a blood test called PAC-MANN that is said to be less invasive, cheaper and more robust than traditional screening methods for ...
A new mRNA vaccine could prevent pancreatic cancer from returning — potentially for the long haul. In a small clinical trial, some patients who received the vaccine remained cancer-free for more than ...
Scientists at Duke-NUS Medical School have identified a molecular “switch” that determines whether pancreatic cancer cells resist chemotherapy or respond to it—a finding that could help convert some ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results